RARE alert: Shire's next deal could be "transformational"
It's Budget day (here in the UK), so here is a piece of RARE that is completely unconnected to one of the busiest days in financial/political journalism.
I hear Shire's next deal is likely to be "transformational".
Since Flemming Ornskov took the helm of pharmaceutical giant he has carried out quite a few major deals, such as this year's $5.2 billion acquisition of NPS or the $4.2 billion purchase of ViroPharma in 2013...
Register
Register for free to see rest of this article and all public articles from Betaville
Login / RegisterDate: Wednesday, 18 March 2015, 5:17 pm